Skip to Content

20 (Rabeprazole Sodium Delayed-Release 20 mg)

Pill with imprint 20 is Yellow, Round and has been identified as Rabeprazole Sodium Delayed-Release 20 mg. It is supplied by Ascend Laboratories LLC.

Rabeprazole is used in the treatment of barrett's esophagus; erosive esophagitis; duodenal ulcer; duodenal ulcer prophylaxis; gerd and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Rabeprazole 20 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 20

Rabeprazole sodium delayed-release 20 mg 20
Rabeprazole sodium delayed-release 20 mg 20
Rabeprazole sodium delayed-release 20 mg 20

Rabeprazole Sodium Delayed-Release

Imprint
20
Strength
20 mg
Color
Yellow
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Proton pump inhibitors
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Ascend Laboratories LLC
Manufacturer
Alkem Laboratories Limited
National Drug Code (NDC)
67877-0443
Inactive Ingredients
mannitol, crospovidone, magnesium oxide, isopropyl alcohol, sodium stearyl fumarate, magnesium stearate, ethylcelluloses, hypromellose phthalate (31% phthalate, 170 cst), carnauba wax, alcohol, diacetylated monoglycerides, polyvinyl alcohol, magnesium silicate, titanium dioxide, polyethylene glycol, soya lecithin, ferric oxide yellow, shellac, ferrosoferric oxide, propylene glycol, butyl alcohol, ammonia, hydroxypropyl cellulose (type h)

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Related Images for "20"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.